ViaLongeVita

From the Czech desk of MedScopeGlobal. Shared with attribution — the local desk added context for this edition.

Glycemic Outcomes After Switching from SGLT2 Inhibitors to DPP-4 Inhibitors in Type 2 Diabetes, with a Comparison of Teneligliptin and Other Agents: A Retrospective Cohort StudyVIP

Medicina (Kaunas) — Lim JY, Song M, Kang YE

From the Czech desk of MedScopeGlobal

6 de agosto de 2026

Salvar

Este conteúdo não é diagnóstico médico nem recomendação de tratamento. Consulte sempre o seu médico ou o SUS.

Illustration for "Glycemic Outcomes After Switching from SGLT2 Inhibitors to DPP-4 Inhibitors in Type 2 Diabetes, with a Comparison of Teneligliptin and Other Agents: A Retrospective Cohort Study" — current health topic, diverse group of adults

Did this article help? Leave a tip — you keep the next reader reading

Medicina (Kaunas) — Lim JY, Song M, Kang YE

Pro váš zájem

Tento obsah je součástí MedScope VIP

Na základě vašeho zájmu o medicínu jsme pro vás připravili plný přístup k odborným článkům, alertům a AI asistentovi.

14 dní zkušební verze zdarma — vyzkoušejte bez rizika

Odemknout předplatným

Již máte účet? Přihlásit se · Srovnání tarifů

Support the author (MedScopeGlobal Editorial) · Tip

Optional micro-contribution — like a tip. When you give, the next reader still gets a clear health text.

A tip is not a VIP subscription and does not unlock paid content — it is optional support for the desk.

Contribution

Donate

A micro-donation keeps clear health writing open for the next person.

Conteúdo recomendado

Artigos

Prepared by the MedScopeGlobal.com editorial team — educational health content for the public. Always consult a physician for personal medical decisions.

Support the author (MedScopeGlobal Editorial) · Tip

Leitura relacionada

Peso sustentável no Brasil: prato repetível, caminhada, GLP-1 com a UBS

Longevidade: healthspan começa no sono, não no suplemento

Biohacking com evidência: o relógio conta passos, não trata

Conteúdo recomendado

Artigos